ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
5 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
437
|
144K
|
5
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
5 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
437
|
144K
|
5
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
7 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
437
|
144K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
Doug Diamond
|
58 |
9.3K |
6 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
9.3K
|
6
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
7 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
137
|
61K
|
7
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
10 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
437
|
144K
|
10
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
9 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
437
|
144K
|
9
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
6 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
437
|
144K
|
6
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
437
|
144K
|
8
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
11 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
437
|
144K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Encouraging Initial Data from CYP-006TK DFU Trial
|
|
Doug Diamond
|
49 |
9.5K |
11 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
49
|
9.5K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Encouraging Initial Data from CYP-006TK DFU Trial
|
|
Doug Diamond
|
49 |
9.5K |
15 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
49
|
9.5K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Encouraging Initial Data from CYP-006TK DFU Trial
|
|
Doug Diamond
|
49 |
9.5K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
49
|
9.5K
|
7
|
|
ASX - By Stock
|
WHK |
Re:
WHK chart
|
|
Doug Diamond
|
437 |
144K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
437
|
144K
|
4
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Response to ASX Price Query
|
|
Doug Diamond
|
32 |
11K |
4 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
32
|
11K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
Doug Diamond
|
20 |
4.9K |
13 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
20
|
4.9K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Doug Diamond
|
21 |
5.2K |
6 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
21
|
5.2K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
Doug Diamond
|
37 |
11K |
5 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
37
|
11K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
Doug Diamond
|
20 |
4.9K |
5 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
20
|
4.9K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
Doug Diamond
|
511 |
115K |
10 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
511
|
115K
|
10
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
Doug Diamond
|
35 |
10K |
8 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
35
|
10K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
Doug Diamond
|
37 |
11K |
14 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
37
|
11K
|
14
|
|
ASX - By Stock
|
WHK |
Re:
Ann: US$1.2m AI Cyber Risk contract. Top 5 Social Media Co.
|
|
Doug Diamond
|
20 |
7.5K |
6 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
20
|
7.5K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Recruitment Completed in Phase 3 OA Clinical Trial
|
|
Doug Diamond
|
5 |
1.6K |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
5
|
1.6K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Recruitment Completed in Phase 3 OA Clinical Trial
|
|
Doug Diamond
|
5 |
1.6K |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
5
|
1.6K
|
3
|
|
ASX - By Stock
|
WHK |
Re:
Ann: US$1.2m AI Cyber Risk contract. Top 5 Social Media Co.
|
|
Doug Diamond
|
20 |
7.5K |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
20
|
7.5K
|
5
|
|
ASX - By Stock
|
WHK |
Re:
Ann: US$1.2m AI Cyber Risk contract. Top 5 Social Media Co.
|
|
Doug Diamond
|
20 |
7.5K |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
20
|
7.5K
|
5
|
|
ASX - By Stock
|
WHK |
Re:
Ann: US$1.2m AI Cyber Risk contract. Top 5 Social Media Co.
|
|
Doug Diamond
|
20 |
7.5K |
9 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
20
|
7.5K
|
9
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Receipt of Clinichain Trial Funds
|
|
Doug Diamond
|
34 |
7.6K |
9 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
34
|
7.6K
|
9
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
137
|
61K
|
4
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX - Go-to-Market (GTM) & Product Development Update
|
|
Doug Diamond
|
123 |
33K |
3 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
123
|
33K
|
3
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
6 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
137
|
61K
|
6
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
Doug Diamond
|
20 |
6.8K |
8 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
20
|
6.8K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
Doug Diamond
|
43 |
8.5K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
43
|
8.5K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
Doug Diamond
|
43 |
8.5K |
3 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
43
|
8.5K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
Doug Diamond
|
43 |
8.5K |
8 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
43
|
8.5K
|
8
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Becoming a substantial holder
|
|
Doug Diamond
|
1 |
742 |
7 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
1
|
742
|
7
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Quarterly Activities Report and Appendix 4C - quarterly
|
|
Doug Diamond
|
20 |
6.8K |
9 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
20
|
6.8K
|
9
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
137
|
61K
|
4
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
137
|
61K
|
3
|
|
ASX - By Stock
|
WHK |
Re:
CYBER SECURITY
|
|
Doug Diamond
|
137 |
61K |
3 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
137
|
61K
|
3
|
|
ASX - By Stock
|
WHK |
Re:
Ann: Half Yearly Report and Accounts
|
|
Doug Diamond
|
6 |
3.3K |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
6
|
3.3K
|
1
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Appendix 4E
|
|
Doug Diamond
|
25 |
5.3K |
12 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
25
|
5.3K
|
12
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Nasdaq IPO & Dual Listing Update
|
|
Doug Diamond
|
75 |
20K |
10 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
75
|
20K
|
10
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Nasdaq IPO & Dual Listing Update
|
|
Doug Diamond
|
75 |
20K |
13 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
75
|
20K
|
13
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Nasdaq IPO & Dual Listing Update
|
|
Doug Diamond
|
75 |
20K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
75
|
20K
|
2
|
|
ASX - By Stock
|
CDX |
Re:
News: CDX Cardiex Ltd - Estimated Initial Public Offering Price Will Be Between $7.50 And $8.00 Per...
|
|
Doug Diamond
|
24 |
4.2K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
24
|
4.2K
|
4
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Doug Diamond
|
1.7K |
566K |
6 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
1.7K
|
566K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant
|
|
Doug Diamond
|
9 |
2.8K |
4 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
9
|
2.8K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant
|
|
Doug Diamond
|
9 |
2.8K |
8 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
9
|
2.8K
|
8
|
|